Thank you, Mr. Chairman, and thank you to our panel this morning.
It's a very interesting take on a few very key issues for an important industry, in the case of the insurance industry. And thank you to Mr. Long for your insights this morning as well.
I'd like to direct my first question to Mr. Yakabuski.
This is specifically on the area of work product. You spent some time on that, and you said that in the current PIPEDA legislation, it is an inhibitor of innovation, research, and so on. Using the notes that were supplied to me by the Dominion of Canada--thank you very much--I was able to find the Privacy Commissioner's comments on that topic of work product.
She appreciates the fact that this is a complex area, but raises some concerns that if we go for a complete blanket exemption of work product information with respect to PIPEDA, it raises the spectre of, for example, video surveillance in the workplace, that type of information. What prevents that from falling into the realm of personal information? That's one issue. I wonder if you could perhaps address the Privacy Commissioner's concerns in that regard.
Secondly, you mention that there is an ability to draw a line, in fact, between when the information regarding an employee--in this case--is personal information and when it's work product. Can you just give us an example of how that might work?